Dog Skin Irritation: Comprehensive Veterinary Reference Guide

Quick Q&A

Question: What is the most common cause of dog skin irritation, and when should I see a veterinarian? Answer: The most common causes include allergic dermatitis (flea, food, or environmental), bacterial pyoderma, and parasitic infestations. You should see a veterinarian if your dog has persistent scratching, redness, hair loss, pustules, or a foul odor, as these often require prescription treatments and diagnostic testing to identify the underlying trigger.

Introduction

Canine skin irritation, medically termed pruritus or dermatitis, is one of the most frequent reasons for veterinary consultations worldwide. It encompasses a broad spectrum of conditions, from mild, transient itching to severe, chronic inflammatory skin disease that significantly impairs a dog's quality of life. This comprehensive veterinary reference guide provides an exhaustive, evidence-based overview of dog skin irritation, covering its pathophysiology, aetiology, diagnostic approach, treatment modalities, and preventative strategies. It is designed for veterinary professionals, veterinary students, and dedicated pet owners seeking a deep understanding of this complex topic.

The skin is the largest organ of the canine body, serving as a critical barrier against environmental pathogens, allergens, and physical trauma. When this barrier is compromised, a cascade of inflammatory responses is triggered. The primary symptom, pruritus (itching), is a complex neurological and immunological sensation that drives dogs to scratch, lick, bite, or rub affected areas, often leading to self-trauma, secondary infections, and a cycle of worsening inflammation. Understanding the root cause of this irritation is paramount for effective management.

This guide synthesises current scientific literature, including recent studies on novel therapeutics and feed additives, alongside established clinical guidelines from authoritative bodies such as the American Veterinary Medical Association (AVMA), the European Food Safety Authority (EFSA), and the Merck Veterinary Manual. We will explore the common and rare causes, the diagnostic reasoning process, and a tiered approach to treatment, from topical therapies to systemic immunomodulation. By the end of this article, readers will have a robust framework for understanding and managing dog skin irritation in a clinical or home setting.

Section 1: The Canine Integumentary System and Pathophysiology of Irritation

To understand skin irritation, one must first appreciate the normal structure and function of the canine skin. The skin is composed of three primary layers: the epidermis (outermost), the dermis (middle), and the hypodermis (subcutis). The epidermis, particularly the stratum corneum, acts as the primary physical and chemical barrier. It is populated by keratinocytes, melanocytes, and Langerhans cells, which are key players in the skin's immune surveillance. The dermis provides structural support via collagen and elastin fibres, houses blood vessels, nerve endings, and adnexal structures like hair follicles and sebaceous glands.

Pathophysiology of Pruritus and Inflammation

Pruritus is not a disease itself but a symptom of an underlying disorder. It arises from the activation of specialised nerve fibres (pruriceptors) in the skin by various pruritogenic mediators. These mediators include histamine (released from mast cells), proteases, cytokines (e.g., IL-31, IL-4, IL-13), and neuropeptides (e.g., substance P).

In allergic skin disease, the process typically begins with allergen exposure. In atopic dermatitis, for example, environmental allergens (pollens, dust mites) penetrate a compromised skin barrier. Langerhans cells capture these allergens and present them to T-lymphocytes, skewing the immune response towards a Th2-dominant phenotype. This leads to the production of IgE antibodies, which bind to mast cells. Upon subsequent allergen exposure, mast cells degranulate, releasing histamine and other mediators, causing immediate pruritus and vasodilation. The chronic inflammatory cascade involves the recruitment of eosinophils, macrophages, and further T-cell activation, perpetuating the itch-scratch cycle.

In bacterial pyoderma, typically caused by Staphylococcus pseudintermedius, the bacteria exploit a disrupted skin barrier. They produce toxins and enzymes that directly damage tissue and trigger a robust inflammatory response. The host's immune system releases cytokines and chemokines, attracting neutrophils to the site, which form pustules. The pruritus associated with pyoderma is often intense and driven by both the bacterial components and the host's inflammatory mediators. Recent research has explored novel antibacterial agents, such as essential oil-loaded hydrogels, which show promise against S. pseudintermedius [1].

Parasitic infestations, such as those from fleas (Ctenocephalides felis), mites (Sarcoptes scabiei, Demodex canis), or lice, cause irritation through direct mechanical trauma, salivary antigens (in the case of fleas), and the host's hypersensitivity reaction. Flea allergy dermatitis (FAD) is a classic example of a hypersensitivity reaction to flea saliva, resulting in intense pruritus, particularly over the dorsum, tail head, and inner thighs.

Section 2: Aetiology and Differential Diagnoses for Dog Skin Irritation

The causes of dog skin irritation are numerous and often overlapping. A systematic approach to differential diagnoses is essential. The major categories include:

2.1 Allergic Dermatitis

This is the most common group of causes.

• Flea Allergy Dermatitis (FAD): A hypersensitivity reaction to flea saliva. Clinical signs include intense pruritus, papules, crusts, and alopecia, typically affecting the lumbosacral area, tail head, and caudal thighs.
• Atopic Dermatitis (AD): A genetically predisposed, chronic inflammatory and pruritic skin disease with a characteristic distribution (face, ears, paws, flexural surfaces, ventrum). It is triggered by environmental allergens.
• Food Allergy (Cutaneous Adverse Food Reaction): An adverse reaction to a dietary component, often a protein (beef, chicken, dairy) or carbohydrate. It is non-seasonal and can present with pruritus, recurrent pyoderma, otitis externa, and gastrointestinal signs.
• Contact Dermatitis: A less common allergic or irritant reaction to a substance the dog directly contacts (e.g., certain plants, shampoos, carpets, lawn chemicals). Lesions are typically confined to sparsely haired areas like the ventrum, groin, and paws.

2.2 Infectious Causes

• Bacterial Pyoderma: A bacterial infection of the skin, most commonly caused by Staphylococcus pseudintermedius. It can be superficial (impetigo, superficial folliculitis) or deep (furunculosis, cellulitis). Clinical signs include pustules, papules, epidermal collarettes, alopecia, and crusting.
• Malassezia Dermatitis: An overgrowth of the commensal yeast Malassezia pachydermatis. It is often secondary to allergic skin disease or endocrinopathies. It causes greasy, erythematous skin, a characteristic "yeasty" odour, and intense pruritus, often affecting the ears, lips, skin folds, and paws.
• Dermatophytosis (Ringworm): A fungal infection of the hair shafts and skin, caused by Microsporum canis, Microsporum gypseum, or Trichophyton mentagrophytes. It presents as circular areas of alopecia, scaling, and crusting. It is zoonotic.

2.3 Parasitic Infestations

• Sarcoptic Mange (Scabies): Caused by Sarcoptes scabiei var. canis. It is highly contagious and causes severe, intense pruritus. Typical lesions include papules, crusts, and alopecia on the ear margins, elbows, hocks, and ventrum.
• Demodectic Mange: Caused by Demodex canis mites. It is not typically pruritic unless secondary pyoderma is present. Localised demodicosis is common in young dogs, while generalised demodicosis can indicate underlying immunosuppression.
• Cheyletiellosis ("Walking Dandruff"): Caused by Cheyletiella mites. It causes scaling and mild to moderate pruritus along the dorsum.
• Pediculosis (Lice): Infestation with biting or sucking lice. It causes pruritus, alopecia, and a dry, scaly coat.
• Hookworm Dermatitis: Caused by Ancylostoma caninum larvae penetrating the skin, typically on the paws, causing papules and pruritus.

2.4 Endocrine and Metabolic Disorders

• Hypothyroidism: A deficiency in thyroid hormone. Clinical signs include bilaterally symmetrical alopecia, hyperpigmentation, pyoderma, seborrhea, and a "rat tail." Pruritus is typically absent unless secondary infection is present.
• Hyperadrenocorticism (Cushing's Disease): Excess cortisol production. Signs include alopecia, thin skin, calcinosis cutis (calcium deposition in the skin), pyoderma, and comedones.
• Sex Hormone Imbalances: Can occur in intact or neutered animals, leading to alopecia and skin changes.

2.5 Other Causes

• Autoimmune and Immune-Mediated Diseases: Pemphigus foliaceus, lupus erythematosus, and erythema multiforme. These are less common but can cause severe skin irritation, ulceration, and crusting.
• Neoplasia: Cutaneous lymphoma, mast cell tumours, and squamous cell carcinoma can present with irritation, ulceration, and pruritus. Mast cell density in squamous cell carcinoma has been a subject of recent study [25].
• Environmental Irritants: Contact with harsh chemicals, soaps, or plants.
• Psychogenic Dermatitis: Obsessive-compulsive licking, often in anxious or bored dogs, leading to acral lick dermatitis (a thickened, ulcerated plaque on a limb).
• Urine Scalding: Irritation and inflammation of the skin due to prolonged contact with urine, common in incontinent or recumbent dogs. Recent work has detailed the clinical and histopathological features of this condition [10].

Section 3: Diagnostic Approach to the Pruritic Dog

A thorough diagnostic workup is crucial for identifying the underlying cause of dog skin irritation and guiding effective treatment. The approach should be systematic and evidence-based.

3.1 History and Signalment

A detailed history is the cornerstone of diagnosis. Key questions include:

• Signalment: Age, breed, sex. Certain breeds are predisposed to atopic dermatitis (e.g., West Highland White Terrier, Labrador Retriever, French Bulldog, Golden Retriever).
• Onset and Duration: When did the irritation start? Is it seasonal or non-seasonal?
• Progression: Is it getting worse, staying the same, or improving?
• Pruritus Severity: Use a validated pruritus scale (e.g., a 0-10 visual analogue scale). Does the dog scratch, lick, bite, or rub? Does it interfere with sleep or play?
• Lesion Distribution: Where on the body are the lesions? (e.g., face, ears, paws, ventrum, dorsum, tail head).
• Response to Previous Treatments: Has any medication (topical, oral, or injectable) been tried? What was the response? This is critical for ruling out conditions like sarcoptic mange, which is exquisitely sensitive to certain parasiticides.
• Diet and Environment: What is the dog's current diet? Any recent changes? Is the dog on flea and tick prevention? What is the home environment like (carpets, houseplants, cleaning products)?
• Other Animals and People: Are other pets or family members itchy? This can suggest a contagious or zoonotic cause (e.g., scabies, ringworm).

3.2 Physical Examination

A complete physical examination, with a focus on the skin, is performed. The veterinarian will assess:

• Primary Lesions: Pustules, papules, vesicles, wheals.
• Secondary Lesions: Alopecia, scales, crusts, excoriations, lichenification, hyperpigmentation, epidermal collarettes.
• Specific Body Regions: Examine the ear canals (otitis externa), interdigital spaces, lips, perianal area, and skin folds.
• General Health: Assess for signs of systemic disease (e.g., lymphadenopathy, thyroid enlargement, pot-bellied appearance).

3.3 In-Office Diagnostic Tests

These are essential, inexpensive, and provide immediate information.

• Skin Scraping: A superficial and deep scraping is performed to detect mites (Demodex, Sarcoptes). Multiple scrapings may be needed for scabies.
• Cytology: Tape strip or impression smear of pustules, papules, or exudate. This is critical for identifying bacteria (cocci, rods), yeast (Malassezia), and inflammatory cells (neutrophils, eosinophils).
• Trichogram (Hair Pluck): Examination of plucked hairs to assess hair shaft structure, presence of fungal spores (dermatophytosis), or mites.
• Wood's Lamp Examination: A UV light used to screen for Microsporum canis (some strains fluoresce apple-green). This is a screening tool, not a definitive test.

3.4 Advanced Diagnostic Tests

• Fungal Culture: The gold standard for diagnosing dermatophytosis. Hairs and scales are placed on a special medium (DTM) to culture the fungus.
• Bacterial Culture and Sensitivity (C&S): Indicated for deep pyoderma, recurrent pyoderma, or when antibiotic resistance is suspected. It identifies the specific bacteria and which antibiotics will be effective.
• Allergy Testing:
  • Intradermal Testing (IDT): Considered the gold standard for environmental allergies. Small amounts of allergens are injected into the skin to observe for a wheal-and-flare reaction.
  • Serum Allergy Testing (IgE): A blood test that measures allergen-specific IgE levels. It is less invasive but can have false positives and negatives.
• Dietary Elimination Trial: The gold standard for diagnosing food allergy. The dog is fed a strict novel protein or hydrolysed protein diet for 8-12 weeks. If pruritus resolves, a food challenge is performed to confirm the diagnosis.
• Skin Biopsy: Indicated for suspected autoimmune disease, neoplasia, or unusual, non-responsive dermatoses. A full-thickness punch biopsy is submitted for histopathology.
• Blood Work: A complete blood count (CBC), serum biochemistry, and thyroid panel (T4, TSH) are useful for ruling out endocrine causes (hypothyroidism, Cushing's disease) and assessing overall health.

Section 4: Treatment and Management of Dog Skin Irritation

Treatment is directed at the underlying cause whenever possible. A multimodal approach is often required, especially for chronic conditions like atopic dermatitis.

4.1 Parasite Control

• Flea and Tick Prevention: Year-round, rigorous flea control is essential for all dogs, especially those with FAD. Options include topical spot-ons (e.g., fipronil, selamectin, imidacloprid), oral medications (e.g., afoxolaner, fluralaner, sarolaner, lotilaner), and collars (e.g., flumethrin/imidacloprid).
• Antiparasitic Therapy: For sarcoptic mange, cheyletiellosis, and lice, treatments include selamectin, moxidectin, ivermectin (use with caution in herding breeds), or lime sulfur dips.

4.2 Topical Therapy

Topical therapy is a cornerstone of managing skin irritation. It directly targets the skin barrier and reduces surface pathogens.

• Shampoo Therapy: Medicated shampoos are used to cleanse the skin, remove debris, and deliver active ingredients.
  • Antibacterial/Antiseptic: Chlorhexidine, benzoyl peroxide, ethyl lactate. These are effective against Staphylococcus pseudintermedius and Malassezia.
  • Antifungal: Ketoconazole, miconazole, chlorhexidine.
  • Antipruritic/Soothing: Oatmeal, colloidal oatmeal, aloe vera, pramoxine.
  • Keratolytic/Seborrheic: Salicylic acid, sulfur, tar.
  • Moisturising: Humectants and emollients to restore the skin barrier.
  • A recent study demonstrated the efficacy of a standardised Ophytrium-containing shampoo and leave-on mousse protocol in reducing pruritus and skin irritation in dogs [20].
• Spot-Ons and Sprays: These are convenient for localised treatment. They often contain similar active ingredients to shampoos (e.g., chlorhexidine, miconazole, hydrocortisone).
• Leave-On Conditioners and Mousses: Provide sustained moisturisation and can deliver active ingredients like phytosphingosine, which supports the skin barrier.
• Topical Corticosteroids: Hydrocortisone, triamcinolone, or betamethasone creams/sprays can be used for short-term relief of localised inflammation. They should be used cautiously due to potential for skin atrophy with prolonged use.
• Topical Immunomodulators: Tacrolimus and pimecrolimus are calcineurin inhibitors used for localised atopic dermatitis (e.g., facial or ear involvement). They are steroid-sparing.

4.3 Systemic Therapy

• Antipruritics:
  • Oclacitinib (Apoquel): A Janus kinase (JAK) inhibitor that blocks the production of multiple pruritogenic cytokines (e.g., IL-31). It is highly effective for the rapid relief of pruritus associated with allergic dermatitis. A recent study explored a temperature-responsive hydrogel formulation of oclacitinib for rectal administration, which may offer an alternative delivery route [5].
  • Lokivetmab (Cytopoint): A caninised monoclonal antibody that neutralises IL-31. It provides rapid, targeted relief of pruritus for 4-8 weeks per injection.
  • Glucocorticoids (Prednisone, Prednisolone, Triamcinolone): Potent anti-inflammatory and antipruritic agents. They are effective but have significant potential for side effects (polyuria, polydipsia, polyphagia, panting, immunosuppression, iatrogenic Cushing's) with long-term use. They are best used for short-term flare-ups or as a bridge to safer therapies.
  • Antihistamines: Cetirizine, diphenhydramine, chlorpheniramine. They are generally less effective in dogs than in humans but may be helpful in some cases, particularly for mild pruritus or as adjunctive therapy.
• Antibiotics: Systemic antibiotics are required for deep pyoderma or when topical therapy alone is insufficient. The choice of antibiotic should ideally be guided by culture and sensitivity. Common choices include cephalexin, cefpodoxime, clindamycin, and amoxicillin-clavulanate. The duration of therapy is typically 3-4 weeks or until 1-2 weeks beyond clinical resolution.
• Antifungals: Systemic antifungals (e.g., ketoconazole, itraconazole, fluconazole) are used for severe or widespread Malassezia dermatitis or dermatophytosis. They require monitoring for hepatotoxicity.
• Immunomodulators (Steroid-Sparing):
  • Cyclosporine (Atopica): A calcineurin inhibitor that suppresses T-cell activation. It is effective for the long-term management of atopic dermatitis. Side effects include vomiting, diarrhoea, and gingival hyperplasia.
• Allergen-Specific Immunotherapy (ASIT): Also known as allergy shots or sublingual immunotherapy. This is the only disease-modifying treatment for atopic dermatitis. It involves administering gradually increasing doses of the identified allergens to induce immunological tolerance. It is highly effective in 60-80% of cases but takes several months to show benefit.

4.4 Dietary Management

• Elimination Diet: As discussed, this is the gold standard for diagnosing and managing food allergy.
• Essential Fatty Acid (EFA) Supplementation: Omega-3 and omega-6 fatty acids (e.g., fish oil, evening primrose oil) have anti-inflammatory properties and can support skin barrier function. They are often used as adjunctive therapy.
• Probiotics and Prebiotics: Emerging evidence suggests that the gut microbiome influences skin health (the gut-skin axis). The EFSA has assessed several feed additives, including Enterococcus lactis and a multi-strain probiotic (FlorEquilibre Chien), for their safety and efficacy in dogs [4, 9]. These may play a role in modulating the immune response and reducing allergic inflammation.
• Novel Feed Additives: The EFSA has evaluated numerous botanical extracts and essential oils for use as feed additives. These include extracts from cranberry (Vaccinium macrocarpon) [3], common ivy and thymol [2], and various essential oils (thyme, rosemary, lavender, tea tree, sage, clary sage, patchouli, caraway) [7, 11, 12, 14, 15, 16, 17, 18, 21, 28, 32, 34, 35, 36, 40]. While many are deemed safe, their specific dermatological benefits in dogs require further investigation. Some, like rosemary tinctures and oils, have known antioxidant and anti-inflammatory properties [11, 12]. Others, like a proanthocyanidin-rich cranberry extract, are being considered for their general health benefits [3].

4.5 Environmental Management

• Allergen Avoidance: For dogs with identified environmental allergies, measures can include using air purifiers with HEPA filters, washing bedding in hot water, avoiding walks during high pollen counts, and wiping paws after walks.
• Humidity Control: Maintaining optimal humidity (40-60%) can help prevent dry skin.

Section 5: Prevention and Long-Term Management

Prevention is always better than cure. For many dogs, skin irritation is a chronic condition that requires lifelong management.

• Routine Parasite Prevention: Year-round flea and tick control is non-negotiable.
• Optimal Skin Barrier Care: Regular bathing with a gentle, moisturising shampoo (every 2-4 weeks) can help maintain a healthy skin barrier. Avoid over-bathing, which can strip natural oils.
• High-Quality Diet: Feed a balanced, high-quality diet appropriate for the dog's life stage. For dogs with known food allergies, strict adherence to the elimination diet is crucial.
• Early Intervention: At the first sign of itching or skin changes, initiate prompt treatment (e.g., topical therapy, antihistamines) to prevent the itch-scratch cycle from escalating.
• Regular Veterinary Check-ups: Annual or biannual wellness exams allow for early detection of skin issues and monitoring of chronic conditions.
• Weight Management: Obesity can exacerbate skin fold dermatitis and make it difficult to perform topical treatments.
• Stress Reduction: For dogs with psychogenic dermatitis, addressing underlying anxiety through environmental enrichment, behavioural modification, and, if necessary, anxiolytic medication is key.

Section 6: Regional Considerations and Zoonotic Potential

6.1 Regional Variations

• North America: Flea allergy dermatitis is common, with Ctenocephalides felis being the primary flea. Tick-borne diseases (e.g., Lyme disease, ehrlichiosis) can have cutaneous manifestations. Demodicosis is frequently seen in young dogs.
• Europe: Similar to North America, with variations in tick species. The EFSA plays a significant role in regulating feed additives and veterinary medicinal products. Leishmaniasis (a protozoal disease transmitted by sandflies) is a major cause of skin disease in Mediterranean countries, presenting with exfoliative dermatitis, alopecia, and ulcerations.
• Australia: Unique tick species like the paralysis tick (Ixodes holocyclus) can cause severe systemic illness. Sarcoptic mange is endemic in some wild dog populations and can be transmitted to domestic dogs. The Australian Veterinary Association (AVA) provides specific guidelines for managing these conditions.
• United Kingdom: The UK is rabies-free, which influences quarantine and import regulations. However, skin diseases are similar to other temperate regions.

6.2 Zoonotic Potential

Several causes of dog skin irritation are zoonotic, meaning they can be transmitted to humans.

• Dermatophytosis (Ringworm): Highly contagious to humans, especially children and immunocompromised individuals. It causes circular, itchy, red lesions on the skin.
• Sarcoptic Mange (Scabies): Can cause intense pruritus in humans, though the mites cannot complete their life cycle on human skin. Lesions typically appear on the arms, trunk, and waist.
• Cheyletiellosis: Can cause a mild, transient dermatitis in humans.
• Hookworm Dermatitis: Larval penetration can cause a pruritic, papular rash in humans (cutaneous larva migrans).

Veterinarians and pet owners should be aware of these risks and practice good hygiene, including hand washing after handling affected animals.

Section 7: Prognosis and When to Refer

The prognosis for dog skin irritation varies greatly depending on the underlying cause.

• Parasitic infestations: Excellent prognosis with appropriate treatment.
• Bacterial pyoderma: Good prognosis, but recurrence is common if the underlying cause (e.g., allergy, endocrinopathy) is not addressed.
• Atopic dermatitis: Chronic, lifelong condition requiring ongoing management. With a multimodal approach, most dogs achieve a good quality of life.
• Autoimmune disease: Variable prognosis, often requiring lifelong immunosuppressive therapy.
• Neoplasia: Prognosis depends on the tumour type, location, and stage.

When to Refer to a Veterinary Dermatologist:

• Severe, non-responsive pruritus.
• Recurrent pyoderma or otitis.
• Suspected autoimmune disease.
• Need for advanced diagnostic testing (IDT, skin biopsy).
• Poor response to standard therapies.
• Cases requiring complex immunotherapy protocols.

Conclusion

Dog skin irritation is a multifaceted and common clinical problem. A systematic, evidence-based approach to diagnosis and treatment is essential for achieving successful outcomes. This involves a thorough history and physical examination, targeted in-office diagnostics, and, when necessary, advanced testing. Treatment must be directed at the underlying cause, often requiring a multimodal strategy that includes parasite control, topical therapy, systemic medications, dietary management, and environmental modifications. With diligent care and a strong partnership between the veterinarian and the pet owner, most dogs with skin irritation can be managed effectively, leading to a significant improvement in their comfort and overall well-being.

References

[1] Jacobs M, Valdivia N, Varas M, et al. Cryptocarya alba and Laureliopsis philippiana Essential Oil-Loaded Hydrogels with Antibacterial Activity Against Staphylococcus pseudintermedius: Potential Topical Candidates for Canine Pyoderma. Vet Sci. 2026. [2] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of an extract from the dried leaves of Hedera helix L. (common ivy extract) and thymol for all animal species and categories except poultry, ornamental birds and all aquatic animal species (FEFANA asbl). EFSA J. 2026. [3] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a proanthocyanidin-rich dry extract from the fruit of Vaccinium macrocarpon Aiton (cranberry extract) for dogs and cats (ACEL pharma S.r.l.). EFSA J. 2026. [4] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Assessment of the feed additive consisting of Enterococcus lactis DSM 10663 NCIMB 10415 (Oralin) for calves for rearing, piglets, chickens for fattening, turkeys for fattening, cats and dogs for the renewal of its authorisation (Chevita Tierarzneimittel GmbH). EFSA J. 2026. [5] Guo P, Yang Y, Zhang Z, et al. Temperature-responsive hydrogel of oclacitinib maleate administered via the rectum in rabbit. Front Vet Sci. 2026. [6] Somers E, Field E, Cinti F, et al. Clinical indications and outcome of omocervical axial pattern flaps in dogs and cats: six cases (2016-2024). J Small Anim Pract. 2026. [7] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of an essential oil obtained from the flowering aerial parts of Thymus vulgaris L. and/or Thymus zygis L. (thyme oil) for use in all animal species (FEFANA asbl). EFSA J. 2025. [8] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Assessment of the feed additive consisting of L-cysteine hydrochloride monohydrate (2b920) for cats and dogs for the renewal of its authorisation (PRINOVA BENELUX AND FRANCE N.V). EFSA J. 2025. [9] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of viable cells of Lactobacillus acidophilus CNCM I-3231, Ligilactobacillus salivarius CNCM I-3233, Lactiplantibacillus plantarum CNCM I-3232, Lacticaseibacillus rhamnosus CNCM I-4427, and Bifidobacterium animalis subsp. lactis CNCM I-3993 (FlorEquilibre Chien) for dogs (Wamine SAS). EFSA J. 2025. [10] McMahill BG, Lau C, Declercq J, et al. Clinical and histopathological features of urine scalding in dogs and cats. Vet Pathol. 2026. [11] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of feed additives consisting of rosemary tinctures obtained from the leaves of Salvia rosmarinus Spenn. for use in all animal species (FEFANA asbl). EFSA J. 2025. [12] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of an essential oil derived from the flowering aerial parts of Salvia rosmarinus Spenn. (rosemary oil) for use in all animal species (FEFANA asbl). EFSA J. 2025. [13] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Assessment of the feed additive neohesperidine dihydrochalcone (2b959) for piglets, pigs for fattening, calves, sheep, fish and dogs for the renewal of its authorisation (Adisseo S.A.S., ADM International Sàrl, Lucta S.A. and Norel S.A.). EFSA J. 2025. [14] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a tincture derived from the leaves or aerial parts of Thymus serpyllum L. (wild thyme tincture) for use in all animal species (FEFANA asbl). EFSA J. 2025. [15] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a tincture derived from the leaves of Salvia officinalis L. (sage tincture) for use in all animal species (FEFANA asbl). EFSA J. 2025. [16] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a tincture derived from the leaves or the aerial parts of Mentha x piperita L. (peppermint tincture) for use in all animal species (FEFANA asbl). EFSA J. 2025. [17] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a tincture derived from the flowers of Lavandula angustifolia Mill. (lavender tincture) for use in all animal species (FEFANA asbl). EFSA J. 2025. [18] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of a tincture derived from the leaves of Ocimum basilicum L. (basil tincture) for use in all animal species (FEFANA asbl). EFSA J. 2025. [19] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of 4-hydroxy-2,5-dimethylfuran-3(2H)-one for all animal species other than dogs and cats (ADISSEO France SAS, ADM International Sàrl, Laboratoires Phodé S.A.S., LUCTA S.A., Norel, S.A.). EFSA J. 2025. [20] Savelli N, Cozar A, Abdesselam M, et al. Effect of a standardised Ophytrium-containing shampoo and a leave-on mousse protocol on dogs with irritated and pruritic skin. J Small Anim Pract. 2025. [21] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of an essential oil derived from the leaves of Pogostemon cablin Benth. (patchouli oil) for use in all animal species (FEFANA asbl). EFSA J. 2025. [22] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Assessment of the feed additive neohesperidine dihydrochalcone for piglets, pigs for fattening, calves, sheep, fish and dogs for the renewal of its authorisation (HealthTech Bio Actives S.L.U.). EFSA J. 2025. [23] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Safety and efficacy of a feed additive consisting of capsaicin for all animal species (XP Chemistries AB). EFSA J. 2025. [24] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al. Assessment of the efficacy of a feed additive consisting of Bifidobacterium longum CN